These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32339447)

  • 1. hIL-7-hyFc, A Long-Acting IL-7, Increased Absolute Lymphocyte Count in Healthy Subjects.
    Lee SW; Choi D; Heo M; Shin EC; Park SH; Kim SJ; Oh YK; Lee BH; Yang SH; Sung YC; Lee H
    Clin Transl Sci; 2020 Nov; 13(6):1161-1169. PubMed ID: 32339447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
    Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions.
    Kim S; Lee SW; Koh JY; Choi D; Heo M; Chung JY; Lee BH; Yang SH; Sung YC; Lee H; Shin EC; Park SH
    Blood Adv; 2022 Dec; 6(23):6093-6107. PubMed ID: 36206199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
    Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma.
    Ahn S; Park JS; Kim H; Heo M; Sung YC; Jeun SS
    Cancer Med; 2023 Mar; 12(6):6778-6787. PubMed ID: 36583472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin.
    Im SJ; Yang SI; Yang SH; Choi DH; Choi SY; Kim HS; Jang DS; Jin KS; Chung YK; Kim SH; Paik SH; Park YC; Chung MK; Kim YB; Han KH; Choi KY; Sung YC
    PLoS One; 2011; 6(9):e24574. PubMed ID: 21957455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects.
    Hussaini A; Mukherjee R; Berdieva DM; Glogowski C; Mountfield R; Ho PTC
    Clin Transl Sci; 2020 Mar; 13(2):337-344. PubMed ID: 31664766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.
    Thiébaut R; Jarne A; Routy JP; Sereti I; Fischl M; Ive P; Speck RF; D'Offizi G; Casari S; Commenges D; Foulkes S; Natarajan V; Croughs T; Delfraissy JF; Tambussi G; Levy Y; Lederman MM
    Clin Infect Dis; 2016 May; 62(9):1178-1185. PubMed ID: 26908786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects.
    Tang KY; Lickliter J; Huang ZH; Xian ZS; Chen HY; Huang C; Xiao C; Wang YP; Tan Y; Xu LF; Huang YL; Yan XQ
    Cell Mol Immunol; 2019 May; 16(5):473-482. PubMed ID: 29670279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
    Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.
    Markowitz M; Frank I; Grant RM; Mayer KH; Elion R; Goldstein D; Fisher C; Sobieszczyk ME; Gallant JE; Van Tieu H; Weinberg W; Margolis DA; Hudson KJ; Stancil BS; Ford SL; Patel P; Gould E; Rinehart AR; Smith KY; Spreen WR
    Lancet HIV; 2017 Aug; 4(8):e331-e340. PubMed ID: 28546090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers.
    Verhamme P; Pakola S; Jensen TJ; Berggren K; Sonesson E; Saint-Remy JM; Balchen T; Belmans A; Cahillane G; Stassen JM; Peerlinck K; Glazer S; Jacquemin M
    Clin Ther; 2010 Jun; 32(6):1205-20. PubMed ID: 20637972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
    Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA.
    Kim A; Oh MS; Lee GH; Song S; Byun MS; Choi D; Yu BY; Lee H
    Antib Ther; 2024 Apr; 7(2):105-113. PubMed ID: 38566969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Fc-fused interleukin-7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy.
    Kim JH; Kim YM; Choi D; Jo SB; Park HW; Hong SW; Park S; Kim S; Moon S; You G; Kang YW; Park Y; Lee BH; Lee SW
    Clin Transl Immunology; 2020; 9(9):e1168. PubMed ID: 32994996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study.
    Tak PP; Thurlings RM; Rossier C; Nestorov I; Dimic A; Mircetic V; Rischmueller M; Nasonov E; Shmidt E; Emery P; Munafo A
    Arthritis Rheum; 2008 Jan; 58(1):61-72. PubMed ID: 18163485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia.
    Yang SH; Yang SI; Chung YK
    Arch Pharm Res; 2012 May; 35(5):757-9. PubMed ID: 22644842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.
    Ellis J; van Maurik A; Fortunato L; Gisbert S; Chen K; Schwartz A; McHugh S; Want A; Santos Franco S; Oliveira JJ; Price J; Coles A; Brown K; Su D; Craigen JL; Yang J; Brett S; Davis B; Cheriyan J; Kousin-Ezewu O; Gray F; Thompson PW; Fernando D
    Br J Clin Pharmacol; 2019 Feb; 85(2):304-315. PubMed ID: 30161291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers.
    Staton TL; Peng K; Owen R; Choy DF; Cabanski CR; Fong A; Brunstein F; Alatsis KR; Chen H
    BMC Pulm Med; 2019 Jan; 19(1):5. PubMed ID: 30616547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Barouch DH; Tomaka FL; Wegmann F; Stieh DJ; Alter G; Robb ML; Michael NL; Peter L; Nkolola JP; Borducchi EN; Chandrashekar A; Jetton D; Stephenson KE; Li W; Korber B; Tomaras GD; Montefiori DC; Gray G; Frahm N; McElrath MJ; Baden L; Johnson J; Hutter J; Swann E; Karita E; Kibuuka H; Mpendo J; Garrett N; Mngadi K; Chinyenze K; Priddy F; Lazarus E; Laher F; Nitayapan S; Pitisuttithum P; Bart S; Campbell T; Feldman R; Lucksinger G; Borremans C; Callewaert K; Roten R; Sadoff J; Scheppler L; Weijtens M; Feddes-de Boer K; van Manen D; Vreugdenhil J; Zahn R; Lavreys L; Nijs S; Tolboom J; Hendriks J; Euler Z; Pau MG; Schuitemaker H
    Lancet; 2018 Jul; 392(10143):232-243. PubMed ID: 30047376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.